The quality of life (QOL) of 79 people with type 1 reaction, energy, pain, physical mobility and sleep. The diabetic patients without neuropathy also had and type 2 diabetes and 37 non-diabetic controls was assessed using the Nottingham Health Profile significantly impaired QOL for 4/6 NHP domains compared with the non-diabetic control group (NHP). The NHP consists of six domains assessing energy, sleep, pain, physical mobility, emotional (p<0.05) (energy, pain, physical mobility and sleep). This quantification of the detrimental effect reactions and social isolation. Symptomatic diabetic neuropathy was present in 41 of the patients. The on QOL of diabetes, and in particular of chronic symptomatic peripheral diabetic neuropathy, neuropathy patients had significantly higher scores (impaired QOL) in 5/6 NHP domains than either emphasizes the need for further research into effective management of these patients. the other diabetic patients ( p<0.01) or the nondiabetic ( p<0.001) controls. These were: emotional
Introduction
Quality of life (QOL) measurements are increasingly aimed to assess the effects of chronic neuropathic pain on QOL in people with diabetes, and to recognized as important in the assessment of chronic evaluate the relationship between this and individual diseases and in evaluating medical outcomes.1-4 aspects of pain. Until recently, there has been little investigation of the effect of diabetes and its complications on QOL and, in particular, little is known of the effects of chronic symptomatic diabetic neuropathy. Such Methods information would be useful as an outcome measure in clinical intervention studies, and also to enable Forty-one patients with chronic painful diabetic treatment strategies to be aimed at improving particuneuropathy were recruited from an adult hospital lar aspects of impaired health. diabetic clinic. All subjects had typical neuropathic Chronic painful symptoms can have a considersymptoms such as tingling, burning and shooting able impact on an individual's life and may be pain, often with nocturnal exacerbation, for at least associated with anxiety, depression, loss of mobility 6 months, principally effecting the lower limbs and independence. Despite diabetic neuropathic (Dyck's stage 2 or 3).8 Patients with other forms of pain occurring in almost 10% of diabetic clinic neuropathy were excluded by clinical history, exampatients,5 there is little information available on its ination and standard blood tests including renal, effects on QOL. The few studies already reported liver and thyroid function tests and vitamin B 12 . Both have not given details of the neuropathic symptoms type 1 and type 2 patients were included. None of present,6 or have examined the effect of increasing the patients had active foot ulceration, significant severity of neuropathy on QOL but given no details peripheral vascular disease or severe intercurrent illness. All patients had had past treatment for painful of the presence or otherwise of pain.7 We therefore diabetic neuropathy but at the time of the study only groups. Spearman's rank test was used to assess any correlation between variables. Fisher's exact test was 19 were on medication (3 mexiletine, 10 tricyclic antidepressants, 1 anticonvulsants, 2 dihydrocodeine used to compare categorical variables. Statistical analyses were performed using ARCUS (copyright and 3 NSAIDs).
Quality of life was assessed using the Nottingham Dr I.A. Buchan, Ormskirk, UK). Data are shown as mean±SEM, or median (95%CIs) for nonHealth Profile (NHP).9-11 The NHP is a well-validated self-reported questionnaire assessing health-related parametric data. QOL within six domains: energy, sleep, pain, physical mobility, emotional reactions and social isolation. The questionnaire takes only a few minutes to Results complete, requiring yes or no responses to 38 simple Basic demographic details of the three groups are statements. Scores range from 0-100, a score of 100 shown in Table 1 . The groups were well matched indicating the presence of all the limitations listed.
for age and sex, and the two diabetic groups were The severity of chronic neuropathic pain was matched for duration of diabetes, diabetic treatment assessed using the McGill pain questionnaire.12 This and metabolic control. The NHP scores for the six questionnaire consists of 20 subclasses of words individual domains in the three groups are shown in describing pain, listed within each subclass in order Table 2 . Higher scores indicate a greater impairment of increasing intensity. The subclasses are grouped of QOL within that particular domain. into three major classes of word descriptors: sensory,
The diabetic group with pain had significantly i.e. words that describe pain in terms of temporal, higher scores for five of the six domains of the NHP spatial, pressure, thermal and other properties; affectthan either of the other two groups, the exception ive, i.e. words that describe pain in terms of tension, being social isolation where scores were similar in fear and autonomic symptoms; evaluative, i.e. all three groups. In these patients there were no describing the overall intensity of the experience of significant relationships between the duration of pain; and a fourth miscellaneous group of words.
either diabetes or pain, metabolic control or body The patients with chronic pain also completed three mass index with any of the individual sections of separate visual analogue scale scores (VAS), using a the NHP. There were significant relationships 10-cm horizontal line,13 representing their pain in between both the severity of pain as measured by the morning, before lunch and late evening. A mean VAS ( p<0.001) and the McGill pain questionnaire of the three values was documented for each patient.
evaluative section ( p<0.001) with the NHP pain Two control groups were also studied: an age-, subsection. Likewise there was a significant relationsex-and diabetic-treatment-matched group was ship between VAS pain scores and the NHP physical recruited from the same diabetic clinic. These mobility section ( p<0.01). There were no significant patients did not have a history of chronic pain relationships between any of the other subsections (chronic pain defined as pain present for at least of the MPQ or VAS with the other four domains of three months ).14 The second control group consisted the NHP. There were no significant differences in of randomly recruited age-and sex-matched non-NHP scores between those patients who were insudiabetic visitors to the same hospital. All subjects lin-treated and those who were treated with oral denied a history of chronic pain and none refused hypoglycaemic agents or by dietary measures alone. to participate. No other exclusion criteria were
The diabetic group without chronic pain also had followed for these two groups. The NHP was comsignificantly higher scores for four of the six domains pleted by all three groups. In the patients with of the NHP than the non-diabetic control group, the diabetes, metabolic control was assessed using glyexceptions being social isolation and emotional reaccated haemoglobin (Auto A1C, Biomen, Croyden:
tion. There was no correlation between individual non-diabetic range 5-8%).
domains of the NHP and the glycated haemoglobin in the patients without chronic pain.
Statistical analysis
Normality of data distribution was assessed by the
Discussion
Shapiro-Wilk test. Differences between the three groups were measured using one-way ANOVA (with Quality of life has been studied using a variety of measures in people with type 1 and type 2 diabetes. comparison of means by modified t test) or the Kruskal-Wallace test, depending on whether data However results have been inconsistent, with several studies reporting little or no disruption,6,16-19 whilst were normally distributed or not. For the latter test, multiple contrasts, using the method described by others report a considerable impact on QOL.3,20-21 Studies have generally shown a reduction in QOL Conover for non-parametric data,15 then elucidated statistically significant differences between individual with worsening metabolic control,5,16,22 although terms of age, treatment type, metabolic control, diabetes duration, ischaemic heart disease and cerebrovascular disease, these factors probably did not studies of cancer patients, freedom from pain is an important aspect of QOL.25,26 In the diabetic group within a single study, disparate results have been with pain, difficulty with sleep was probably due to shown with varying QOL measures.6 In the present neuropathic pain being typically worse at night, study, there was no relationship between metabolic although depression could be a contributory factor. control and QOL in both groups of patients.
Chronic pain patients who are poor sleepers usually This study clearly demonstrates that painful diahave a greater degree of pain and physical disability, betic neuropathy has a considerable impact on QOL as well as higher scores of depression and anxiety.27 as assessed by the NHP. Little information has
The finding that the diabetic control group had a previously been available on the effects of diabetic higher score in the sleep domain of the NHP than neuropathic pain on QOL. In one study, it was non-diabetic controls confirms previous evidence reported that patients with neuropathic symptoms that diabetes itself can adversely affect sleep.28 A had a reduced QOL when assessed by the NHP and reduction in energy has previously been reported in the Functional Limitations Profile, although details both type 1 and type 2 diabetes,20,22 and the present of the exact symptoms were not given.6 In another, study confirmed this, particularly in the patients with the severity of neuropathy, assessed by clinical pain. The association of sleep loss and energy reduction is obvious. examination, was inversely related to QOL but no The reduction in physical mobility was related to treating other aspects of the disorder, not just the pain. For instance, the beneficial role of pain clinics the VAS pain score. Although diabetic neuropathic pain is typically worse at night, it can also be present and the use of multi-disciplinary teams in the management of chronic pain disorders should be during exercise, contributing to the difficulty sometimes in differentiating the cause of pain in the considered.45
In conclusion, chronic neuropathic pain impairs diabetic leg.29 Recently, it has been shown that when chronic diabetic neuropathic pain is reduced there QOL. The severity of the problem emphasizes the need for further research into effective management is an associated increase in exercise tolerance. 30 In the present study, reduced mobility was not due to of such pain. peripheral vascular disease or the presence of foot ulceration, as neither were present in those with pain.
In those with chronic neuropathic symptoms, the Depression has been variably reported in 10-100% modalities have been ineffective, could be aimed at
